Covid-19: what will it take to vaccinate the world?
Synopsis
Three-fifths of the two billion confirmed orders of the AstraZeneca vaccine will go to high-income countries, limiting access for poorer nations.
Synopsis
Israel leads the world in COVID-19 vaccinations, with over 30% of its population receiving at least one dose of the Pfizer vaccine. The country secured this access through a data-sharing agreement with Pfizer. Meanwhile, wealthier nations dominate the global vaccine supply, leaving many countries to consider alternatives from China and Russia, despite concerns about their safety. The documentary outlines the logistical challenges of distributing vaccines, particularly the AstraZeneca vaccine, which could be key for broader access but faces hurdles in poorer regions.
Deep Dive
Why Watch
- Find out how Israel became the most vaccinated nation.
- See the challenges poorer countries face in vaccine distribution.
- Meet the scientists behind the AstraZeneca vaccine.
Did You Know
- Israel has vaccinated over 30% of its population with the Pfizer jab.
- Three-fifths of AstraZeneca's two billion confirmed orders are for high-income countries.
- The AstraZeneca vaccine can be stored in a normal fridge, making it easier to distribute.
Perfect For
Frequently Asked Questions
Which countries are leading the vaccination rollout?
Israel is leading the rollout of the Pfizer jab, with just over 30% of its population having received at least one dose.
What is the main challenge in distributing the AstraZeneca vaccine?
Many poorer countries will struggle to get the AstraZeneca vaccine into arms quickly and safely, despite it being suitable for storage in a normal fridge.
How many confirmed orders of AstraZeneca doses are allocated to high-income countries?
Three-fifths of the two billion confirmed orders of AstraZeneca doses will go to high-income countries.
What are people saying?
Play More Like This
Where else to watch
Browse more like this
Related Films
Is this your film?
If you made this film or hold the rights to it, we'd like to talk. We can license it and pay you a share of what it earns.





























Comments